News

  • Aug 2025

    A Landmark Disovery in Progeria

    In 2003, Francis Collins, MD, PhD, former NIH Director, and Senior Investigator at the National Human Genome Research Institute (NHGRI), and his colleagues published a groundbreaking paper using samples found in the NIA Aging Cell Repository at Coriell, sponsored by the National Institute on Aging (NIA). Their research discovered the genetic cause of progeria, a point mutation of the Lamin A gene, which helps maintain the normal structure and function of a cell’s nucleus.

    read more

  • Aug 2025

    2024 Annual Report

    2024 marked another year of remarkable progress and achievement at Coriell.

    read more

  • Jul 2025

    Coriell, the bank paying scientific dividends

    Did you know that in 1995 researchers used two cell lines preserved in Coriell’s renowned biobank, the NIGMS Human Genetic Cell Repository, to make a game-changing medical discovery?

    read more

  • Jun 2024

    Computing Biology: How Bioinformatics is Making a Difference at Coriell

    Coriell’s bioinformatics scientists are an essential part of our team. They play a critical role in our cancer research, help make the samples in our care more accessible, and collaborate with scientists all over the world. Gennaro Calendo is the Associate Director of Bioinformatics at Coriell and answered a few questions about his team and their work.

    read more

  • May 2024

    The Chromosome Connection: Unveiling Sex-Based Cancer Mysteries

    Dr. Nora Engel's research focuses on the disparities between the biological sexes in progression and metastasis of melanoma, but better understanding these factors for melanoma can also elucidate how our sex chromosomes may affect our risk for other forms of cancer, as well as other diseases. Here, Dr. Engel answers questions about her work studying melanoma, why those of us with XY sex chromosomes may be more likely to develop the disease than those of us with other arrangements of sex chromosomes, and what most interests her about her work.

    read more

  • Feb 2024

    Applications Accepted for Research Funding through Epigenetic Therapies SPORE

    Applications are now being accepted for a pair of grants offered by the Epigenetic Therapies SPORE. These $50,000 grants are awarded through its Career Enhancement Program (CEP) and Developmental Research Program (DRP) to scientists interested in developing epigenetic therapies for the treatment of cancer.

    read more

  • Nov 2023

    High Molecular Weight DNA Now Available from Fibroblasts, iPSCs

    High molecular weight DNA (HMW DNA) samples derived from fibroblasts and induced pluripotent stem cells are now available from the National Institute of General Medical Sciences’ Human Genetic Cell Repository.

    read more

  • Oct 2023

    Coriell Institute for Medical Research - 2023 Annual Report

    Explore our 2023 Annual Report to discover the remarkable journey of the Coriell Institute for Medical Research over the past year. From the launch of the Camden Cancer Research Center to the celebration of the NIGMS Repository's 50th anniversary, this report highlights our commitment to advancing cancer research and biomedical science as a whole.

    read more

  • Apr 2023

    How Coriell’s Biobanking Logistics Team Maintains Sample Integrity

    Today at Coriell, one team is responsible for a sample’s care from beginning to end—the Biobanking Logistics team. This department manages a complex and wide range of tasks and responsibilities to ensure the samples in our care are received and stored properly, and shipped with care to researchers.

    read more

  • Feb 2023

    Rare Disease Day: FAQs for Contributing to the NIGMS Human Genetic Cell Repository

    For those affected by a rare disease, there is an accessible way to contribute to the research effort. The Human Genetic Cell Repository (HGCR), sponsored by the National Institute of General Medical Sciences (NIGMS) and hosted at the Coriell Institute, contains many thousands of cell line and DNA samples derived from tissue donations from affected people, allowing researchers to study these diseases and develop new therapies. The collection of samples representing rare diseases is always growing!

    read more